Search Result "Schizophrenia"


The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5104-5114
Author(s): Lakshmi Rajagopal, Bill W Massey, Mei Huang, Yoshihiro Oyamada, Herbert Y. Meltzer

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

Journal: Current Neuropharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 219-238
Author(s): Felice Iasevoli,Carmine Tomasetti,Elisabetta F. Buonaguro,Andrea de Bartolomeis

Assessing Schizophrenia-relevant Cognitive and Social Deficits in Mice: A Selection of Mouse Behavioral Tasks and Potential Therapeutic Compounds

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 32 Year: 2014 Page: 5139-5150
Author(s): Wen-Sung Lai,Chia-Yuan Chang,Wan-Rong Wong,Ju-Chun Pei,Ya-Shan Chen,Wei-Li Hung

The Attentional Set-Shifting Test Paradigm in Rats for the Screening of Novel Pro-Cognitive Compounds with Relevance for Cognitive Deficits in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5060-5068
Author(s): Pascal Jean Denis Goetghebeur, Rebecca Dias

The Role of α5 GABAAReceptor Agonists in the Treatment of Cognitive Deficits in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5069-5076
Author(s): Kathryn M. Gill, Anthony A. Grace

Drugs Targeting SNPrs35753505 of the NRG1 Gene May Prevent the Association of Neurological Disorder Schizophrenia in a Pakistani Population

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 9 Year: 2014 Page: 1604-1614
Author(s): Rukhsana Nawaz,Huma Asif,Asifullah Khan,Hina Ishtiaq,Fatima Shad,Sonia Siddiqui

Risk and Protective Effects of the Complexin-2 Gene and Gene-Environment Interactions in Schizophrenia

Journal: Recent Advances in DNA & Gene Sequences (Discontinued)
Volume: 8 Issue: 1 Year: 2014 Page: 30-34
Author(s): Roksana Zakharyan,Sofi Atshemyan,Anna Boyajyan

Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia

Journal: Current Protein & Peptide Science
Volume: 15 Issue: 7 Year: 2014 Page: 681-690
Author(s): Luca Ferraro,Sarah Beggiato,Dasiel O. Borroto-Escuela,Laura Ravani,William T. O'Connor,Maria C. Tomasini,Andrea C. Borelli,Luigi F. Agnati,Tiziana Antonelli,Sergio Tanganelli,Kjell Fuxe

Increase in Antipsychotic Polypharmacy Treatment in Patients with Schizophrenia Between 1994-2000 and 2010

Journal: Current Psychopharmacology
Volume: 3 Issue: 2 Year: 2014 Page: 108-112
Author(s): Deniz Ceylan,Ahmet Aktener,Berna B. Akdede,Koksal Alptekin

Minocycline as Add-On Treatment Decreases the Negative Symptoms of Schizophrenia; A Randomized Placebo-Controlled Clinical Trial

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 8 Issue: 3 Year: 2014 Page: 211-215
Author(s): Ahmad Ghanizadeh, Sara Dehbozorgi, Motahhar OmraniSigaroodi, Zahra Rezaei

Previous   Next

Go To   Results 11 - 20 of 248

Filter Result

Volume Year
Content Type
Ads
© 2023 Bentham Science Publishers | Privacy Policy